Blueprint raises $146.6M in IPO

Oncology company Blueprint Medicines Corp. (NASDAQ:BPMC) raised $146.6 million on Wednesday through the sale of 8.1 million shares at $18 in an IPO underwritten by Goldman Sachs; Cowen; JMP Securities; and Wedbush Pacgrow. The IPO valued Blueprint at $465 million. The company expects to begin trading Thursday.

Blueprint filed in March to raise up to $100 million. Last week, it said it intended to sell 7.2 million shares at $15-$17. At $16, it would have raised $115 million and been valued at $378 million. ...